↓ Skip to main content

Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, June 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer
Published in
Cochrane database of systematic reviews, June 2013
DOI 10.1002/14651858.cd009620.pub2
Pubmed ID
Authors

Aramide O Lawal, Alfred Musekiwa, Liesl Grobler

Abstract

Epithelial ovarian cancer (EOC) is a life-threatening disease. Most often women become symptomatic only in the advanced stages of the disease, increasing the difficulty of treatment. Whilst the disease responds well to surgery and chemotherapy, the relapse rate is high. New treatments to prevent disease recurrence or progression, prolong survival, and increase the quality of life are needed.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 1%
Colombia 1 1%
Unknown 71 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 19%
Researcher 13 18%
Unspecified 11 15%
Student > Ph. D. Student 10 14%
Student > Bachelor 9 12%
Other 16 22%
Readers by discipline Count As %
Medicine and Dentistry 36 49%
Unspecified 13 18%
Nursing and Health Professions 7 10%
Agricultural and Biological Sciences 5 7%
Social Sciences 5 7%
Other 7 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2013.
All research outputs
#10,024,022
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#8,525
of 8,923 outputs
Outputs of similar age
#102,794
of 148,226 outputs
Outputs of similar age from Cochrane database of systematic reviews
#107
of 125 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,226 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.